Search

Author

Subject

Date issued

Has File(s)

Search Results

Results 141-150 of 384 (Search time: 0.005 seconds).
  • Authors: Marie-Luise, Rübsam MD; Philippe, Kruse MD; Yvonne, Dietzler MD;  Advisor: -;  Co-Author: - (2023)

    Climate change is a global threat, and inhalational anesthetics contribute to global warming by altering the photophysical properties of the atmosphere. On a global perspective, there is a fundamental need to reduce perioperative morbidity and mortality and to provide safe anesthesia. Thus, inhalational anesthetics will remain a significant source of emissions in the foreseeable future. It is, therefore, necessary to develop and implement strategies to minimize the consumption of inhalational anesthetics to reduce the ecological footprint of inhalational anesthesia.

  • Authors: Tuo, Pan; Chen-Yu, Jiang; He, Zhang;  Advisor: -;  Co-Author: - (2023)

    Recent high-quality trials have shown that the anti-inflammatory effects of colchicine reduce the risk of cardiovascular events in patients suffering post-myocardial infarction and chronic coronary disease. The effect of colchicine in patients undergoing non-coronary artery bypass grafting (non-CABG) with cardiopulmonary bypass remains unclear. We aim to evaluate the effect of colchicine on myocardial protection in patients who underwent non-CABG cardiac surgery.

  • Authors: Björn B., Hofmann; Daniel M., Donaldson; Igor, Fischer;  Advisor: -;  Co-Author: - (2023)

    Early computed tomography perfusion (CTP) is frequently used to predict delayed cerebral ischemia following aneurysmatic subarachnoid hemorrhage (aSAH). However, the influence of blood pressure on CTP is currently controversial (HIMALAIA trial), which differs from our clinical observations. Therefore, we aimed to investigate the influence of blood pressure on early CTP imaging in patients with aSAH.

  • Authors: Takuhiro, Moromizato; Ryoto, Sakaniwa; Yasuharu, Tokuda;  Advisor: -;  Co-Author: - (2023)

    Steroids are widely used to modulate the inflammatory reactions associated with coronavirus disease 2019 (COVID-19); however, the optimal upper limit dose of steroid use for acute COVID-19 care remains unclear and currently available data may suffer from a time-dependent bias of no effectiveness or reversed causation given the desperate situation of treatment during this pandemic. Accordingly, the aim of this study was to elucidate the impact of intravenous pulse therapy with methylprednisolone (500 mg or greater per day) on the risk of in-hospital mortality among patients with COVID-19 by controlling for time-dependent bias.